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DISCUSSION & CONCLUSIONS 
REFERENCE & ACKNOWLEDGMENT
Bioactivity guided isolation of an ethanol extract of the root of Psoromanthus schottii (Family Fabaceae) afforded
a new prenylated isoflavone, named schottiin (1), together with four other isoflavones, including fremontone (2),
5,7,4´,5´-tetrahydroxy-2´-(3,3-dimethylallyl)-isoflavone (3), glycyrrhisoflavone (4) and fremontin (5), of which 3
and 4 identified as isomeric mixture. Structures of 1-5 were determined by full spectroscopic analyses. A
comprehensive 2D NMR spectral data has allowed revising the structure of fremontone as 2 from previously
reported 2A. Compound 2 showed weak in-vitro antibacterial activity against methicillin-resistant Staphylococcus
aureus (MRSA). A combination study using a checkerboard assay between fremontone (2) and methicillin
exhibited a synergistic activity with 8-fold decrease in MIC of methicillin, as well as an additive effect with
vancomycin against MRSA ATCC 1708. Compounds 1 and 2 also showed moderate antiplasmodial activity
against chloroquine-sensitive (D6) and -resistant (W2) strains of Plasmodium falciparum with no cytotoxicity to
mammalian Vero cells.
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A comprehensive 2D NMR spectral data has allowed revising the structure of fremontone as 2 from previously reported 2A (Table 1 &
Figures 1, 2). Among them, schottiin (1) showed weak antifungal activity (IC50 19 µg/mL) against C. neoformans. Compound 2, which
contains both 1,1-dimethyl and 3.3-dimethylallyl prenylation groups in the ring B showed weak in-vitro antibacterial activity against
MRSA, but a combination study, using a checkerboard method, of 2 and methicillin exhibited an 8-fold more potent activity (i.e., MIC
12.5 µg/mL), compared to methicillin (MIC 100 µg/mL), while vancomycin and 2 was found to be 2-fold more active (MIC 0.25 µg/mL)
than vancomycin alone (MIC 0.5 µg/mL). On the other hand, the MIC value of 2 was reduced from 12.5 to 3.12 µg/mL, a 4-fold reduction
due to synergism with methicillin, thus 2 displayed a potent synergistic effect (FIC = 0.375) with methicillin and an additive effect with
vancomycin (FIC = 1.0) displaying a potentiation effect with both antibiotics (Table 2).
The antimicrobial activity of prenylated flavonoids and their potentiation effect with antibiotics against MRSA have been reported. Our
study further substantiates that prenylated isoflavone (2) adjuvant therapy with methicillin, may have a potential value to address
antibiotic-induce resistance by MRSA. However, further studies are needed to understand their exact role to combat antibacterial
resistance. Compounds 1 and 2 also showed moderate anti-plasmodial activity against CQ-sensitive (D6) and -resistant (W2) strains of
P. falciparum (IC50 3.7, 3.5, and 1.2, 1.3 µg/mL, respectively, vs. IC50 of reference standards chloroquine and artemisinin 0.02, 0.16, and
0.005, 0.003 µg/mL, respectively), with no cytotoxicity to mammalian Vero cells (IC50 > 4.76 µg/mL).
Table 1. 1H and 13C NMR Spectroscopic data  for compounds 1-2
Table 2. Combination study of compound 2 by checkerboard assay against MRSA
a) MIC of 2 reduced from 12.5 to 3.12 μg/mL, b) MIC of methicillin reduced from >50 to 12.5 μg/mL, c) MIC of vancomycin reduced from 0.5 to 0.25 μg/mL, d) MIC of 
2 reduced from 12.5 to 6.25 μg/mL. . In general, when the MIC of each compound-decreased 4X in the presence of the other, it is considered synergistic; reduction 
of MIC in parentheses. Antimicrobial assays were carried out in triplicate.
Figure 2: COSY  and  key HMBC  correlations of  1 and  2 
Figure 1. Structures of compounds isolated from P. schottii
Root of P. schotti
Southwest Desert Flora
Antimicrobial Assay 
Antimicrobial assays were carried out using a modified 
version of the CLSI (formerly NCCLS) method. 
Antimicrobial Combination Study by 
Checkerboard Method 
The combination study of the compounds was carried out in
MRSA using a standard Checkerboard method. The
fractional inhibitory concentration (FIC) was calculated by
using the following formula: FIC = [A*]/[A] + [B*]/[B], where
[A*] is MIC of compound A in the presence of compound B,
[A] is MIC of compound A alone, [B*] is MIC of compound B
in the presence of compound A, and [B] is MIC of compound
B alone. FIC: ≤0.5 = synergistic; 0.51-1.0 = additive; 1.1-2.0
= indifferent; >2.0 = antagonistic
Antiplasmodial and Cytotoxicity Assay
The antiplasmodial assay was performed against D6
(chloroquine sensitive) and W2 (chloroquine resistant) strains
of P. falciparum using the in-vitro assay. The cytotoxicity of
test samples was determined against a mammalian cell line
(VERO) in order to calculate the selectivity index of
antimalarial activity.
aRecorded at 100 mHz, bRecorded at 400 MHz. cCoupling constant (J) values in Hz. 
*in CDCl3/methanol-d4.**in DMSO-d6
